Hem › Bröstcancer › New Jersey › Newark
Kliniska studier för Bröstcancer i Newark, NJ
18 studier för Bröstcancer söker deltagare vid platser i och runt Newark (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
RekryterarFas 3
- Summit Health, Florham Park · 12 mi bort
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekryterarObservationsstudieFriska volontärer välkomna
- Morristown Medical Center, Morristown · 17 mi bort
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
RekryterarFas 2
- Medical Oncology Hematology Associates, Newark
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
RekryterarFas 1/2
- Summit Medical Group, Florham Park · 12 mi bort
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RekryterarFas 3
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Newark
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Livingston · 9 mi bort
- Summit Medical Group PA, Florham Park · 12 mi bort
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekryterarFas 3
- Summit Medical Group, Florham Park · 12 mi bort
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
RekryterarFas 3
- Summit Medical Group, Florham Park · 12 mi bort
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
RekryterarObservationsstudie
- Summit Medical Group, Florham Park · 12 mi bort
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekryterarFas 3
- Newark Beth Israel Medical Center, Newark
- Cooperman Barnabas Medical Center, Livingston · 9 mi bort
- Morristown Medical Center, Morristown · 17 mi bort
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
RekryterarFas 2
- GSK Investigational Site, Morristown · 17 mi bort
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekryterarFas 3
- Morristown Medical Center, Morristown · 17 mi bort
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Rekryterar
- Rutgers State University of New Jersey Medical School, Newark
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekryterarObservationsstudie
- Morristown Medical Center, Morristown · 17 mi bort
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
Rekryterar
- Summit Health, Florham Park · 12 mi bort
RADIANT: Pre-op Radiation With Abemaciclib and Letrozole
RekryterarFas 1
- RWJBarnabas Health Clara Maas Medical Center, Belleville · 4 mi bort
- Cooperman Barnabas Medical Center, Livingston · 9 mi bort
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
RekryterarFas 2
- RWJBarnabas Health - Newark Beth Israel Medical Center, Newark
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
RekryterarFas 4
- Cancer Center Initiative, Newark
- University Hospital, Newark
- RWJBarnabas Health Newark Beth Israel Medical Center, Newark
- och 2 fler
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
RekryterarFas 3
- Morristown Medical Center, Morristown · 17 mi bort
Bröstcancer-studier i andra städer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andra studier i Newark
- Ryggmärgsskador13 studier
- Icke-småcellig lungcancer13 studier
- Akut myeloid leukemi12 studier
- Hjärtsvikt10 studier
- Metastaserande cancer10 studier
- Hjärt-kärlsjukdom9 studier
- Bukspottkörtelcancer9 studier
- Melanom8 studier
- Cancer (alla typer)7 studier
- Lungcancer7 studier
- Crohns sjukdom7 studier
- Stenos i aortaklaffen6 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.